A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B

In chronic Hepatitis B Virus (HBV) infections HBV-specific T cells are functionally impaired. Immunotherapy may restore HBV-specific T cell responses essential for sustained disease remission off-treatment and induction of a functional cure. Chimigen® Molecules are fusion proteins of antigen(s) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Allan, Motyka, Bruce, Gutfreund, Klaus, Shi, Yuenian Eric, George, Rajan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227630/
https://www.ncbi.nlm.nih.gov/pubmed/31687879
http://dx.doi.org/10.1080/21645515.2019.1689080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227630/
https://www.ncbi.nlm.nih.gov/pubmed/31687879
http://dx.doi.org/10.1080/21645515.2019.1689080

Ejemplares similares